NCBI Summary
The ficolin family of proteins are characterized by the presence of a leader peptide, a short N-terminal segment, followed by a collagen-like region, and a C-terminal fibrinogen-like domain. The collagen-like and the fibrinogen-like domains are also found separately in other proteins such as complement protein C1q, C-type lectins known as collectins, and tenascins. However, all these proteins recognize different targets, and are functionally distinct. Ficolin 1 encoded by FCN1 is predominantly expressed in the peripheral blood leukocytes, and has been postulated to function as a plasma protein with elastin-binding activity. [provided by RefSeq, Jul 2008].
Protein
Protein (NP_001994)
M-ficolin
Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)
FCN1
ficolin 1
Undefined
Curated
Ficolin-like
Ficolins
a/b mixed with b-sheet / Fibrinogen C-ter like
0.819
Protein sequence and protein families (fasta) (326 amino acids) Download
MELSGATMARGLAVLLVLFLHIKNLPAQAADTCPEVKVVGLEGSDKLTILRGCPGLPGAPGPKGEAGVIGERGERGLPGAPGKAGPVGPKGDRGEKGMRGEKGDAGQSQSCATGPRNCKDLLDRGYFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRMDGSVDFYRDWAAYKQGFGSQLGEFWLGNDNIHALTAQGSSELRVDLVDFEGNHQFAKYKSFKVADEAEKYKLVLGAFVGGSAGNSLTGHNNNFFSTKDQDNDVSSSNCAEKFQGAWWYADCHASNLNGLYLMGPHESYANGINWSAAKGYKYSYKVSEMKVRPA
Mol* PDB structure viewerUniLectin3D
Structural models
Model Confidence:
  •    Very high (pLDDT > 90)
  •    Confident (90 > pLDDT > 70)
  •    Low (70 > pLDDT > 50)
  •    Very low (pLDDT < 50)

  AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Some regions with low pLDDT may be unstructured in isolation.

Ligand
Glycan ligands from structural data
GlcNAc
GlcNAc
GalNAc
GalNAc
NeuAc
NeuAc
References
NCBI References (10 PubMed Identifiers)
  • Association of ficolin-1 and ficolin-3 gene variation and pulmonary tuberculosis susceptibility in a Chinese population. [33591573]
  • Association between serum ficolin-1 level and disease progression in primary biliary cholangitis. [32915797]
  • Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults. [32601370]
  • Ficolin-1 gene (FCN1) -144 C/A polymorphism is associated with adverse outcome of severe pneumonia in the under-five Egyptian children: A multicenter study. [32142211]
  • Sickening or Healing the Heart? The Association of Ficolin-1 and Rheumatic Fever. [30619357]
  • Characterization of ficolins as novel elastin-binding proteins and molecular cloning of human ficolin-1. [8947836]
  • Cloning and characterization of the human lectin P35 gene and its related gene. [8884275]
  • A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. [8576206]
  • Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9. [8573080]
  • Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen- and collagen-like domains. [7686157]
UniProt Main References (10 PubMed Identifiers)
  • Complete sequencing and characterization of 21,243 full-length human cDNAs. [14702039]
  • DNA sequence and analysis of human chromosome 9. [15164053]
  • The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
  • Signal peptide prediction based on analysis of experimentally verified cleavage sites. [15340161]
  • Secreted M-ficolin anchors onto monocyte transmembrane G protein-coupled receptor 43 and cross talks with plasma C-reactive protein to mediate immune signaling and regulate host defense. [21037097]
  • Tethering of Ficolin-1 to cell surfaces through recognition of sialic acid by the fibrinogen-like domain. [20400674]
  • Trivalent recognition unit of innate immunity system: crystal structure of trimeric human M-ficolin fibrinogen-like domain. [17148457]
  • Structural basis for innate immune sensing by M-ficolin and its control by a pH-dependent conformational switch. [17897951]
  • Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin. [20032467]
  • The consensus coding sequences of human breast and colorectal cancers. [16959974]
RNA
RNA (Transcript ID: NM_002003.5)
ficolin 1
m7G-5')ppp(5'-GUUAGAGCUGGGGGACUCUUCAGAGUCAAAGGCCAGAGAGCAUGGAGCUGAGUGGAGCCACCAUGGCCCGGGGGCUCGCUGUCCUGCUAGUCUUGUUCCUGCAUAUCAAGAACCUGCCUGCCCAGGCUGCGGACACAUGUCCAGAGGUGAAGGUGGUGGGCCUGGAGGGCUCUGACAAGCUCACCAUUCUCCGAGGCUGCCCGGGGCUGCCCGGGGCCCCAGGGCCAAAGGGAGAGGCAGGUGUCAUUGGAGAGAGAGGAGAACGCGGUCUCCCUGGAGCCCCUGGAAAGGCAGGACCAGUGGGGCCCAAAGGAGACCGAGGAGAGAAGGGGAUGCGUGGAGAGAAAGGAGACGCUGGGCAGUCUCAGUCGUGUGCGACAGGCCCACGCAACUGCAAGGACCUGCUAGACCGGGGGUAUUUCCUGAGCGGCUGGCACACCAUCUACCUGCCCGACUGCCGGCCCCUGACUGUGCUCUGUGACAUGGACACGGACGGAGGGGGCUGGACCGUUUUCCAGCGGAGGAUGGAUGGCUCUGUGGACUUCUAUCGGGACUGGGCCGCAUACAAGCAGGGCUUCGGCAGUCAGCUGGGGGAGUUCUGGCUGGGGAAUGACAACAUCCACGCCCUGACUGCCCAGGGAAGCAGCGAGCUCCGUGUAGACCUGGUGGACUUUGAGGGCAACCACCAGUUUGCUAAGUACAAAUCAUUCAAGGUGGCUGACGAGGCAGAGAAGUACAAGCUGGUACUGGGAGCCUUUGUCGGGGGCAGUGCGGGUAAUUCUCUAACGGGCCACAACAACAACUUCUUCUCCACCAAAGACCAAGACAAUGAUGUGAGUUCUUCGAAUUGUGCUGAGAAGUUCCAAGGAGCCUGGUGGUACGCCGACUGUCAUGCUUCAAACCUCAAUGGUCUCUACCUCAUGGGACCCCAUGAGAGCUAUGCCAAUGGUAUCAACUGGAGUGCGGCGAAGGGGUACAAAUAUAGCUACAAGGUGUCAGAGAUGAAGGUGCGGCCCGCCUAGACGGGCCAGGACCCCUCCACAUGCACCUGCUAGUGGGGAGGCCACACCCACAAGCGCUGCGUCGUGGAAGUCACCCCAUUUCCCCAGCCAGACACACUCCCAUGACGCCCACAGCUGCCCCUUUGCCCCCAGCUCAGUCAAGCCGCCACAUGCCCACAACCUCACCAGAGGGAGAAUUAUGUUUCUAAAUAUGUUUACUUUGGGACAGAAAAGUUUUACCAGUUUCAAUGUGUGUUUCUUGAACACCAGUGGUUUUGAUCACUUUCCUGUGUCUGUUGCACGGCAGGUCUUUCCCUGGAAUUUGGUAAGUCGGGAAGAGUCAGGACCCUUAUUUAGCAGAUGGCACUACCGAUGUUCAGGGAGGUUGAGUGACUUUUGCGAGGAUUUUCCACCUCCAGUAAUUGACACAGGGCGAUCCUCACCUCCACCCCCAAGCCUCCCCCAUCCCCCCAUGCCUCACUCACAACACUUCACACUUCUUGAAAAAGGUCACUUUGGGGUCCAGAAAACACUUACUAAAAAGGGGGAAAGUUUAGUAGGAACUUUUCUGCUUCCCACCACGGCAGAGUUCAUGCUUUGGGCUGGCUGGCUGCUGGGAAGAGAUAAACACUUAGCACUCACUAAGUGAGCGCCUGGUCAGCCACCUGCACAGAGAAGAUUCCGAAGAGGCCUUCCUCCCACACACAGACCUCAGCUAGAGGGGACCGCGGACCUCAGUGGGAAAAGCUGCACAAGGCUUCUAGGAGAUGAUGGAGAAGGGGCUUCUCCAGCUCCCAGGCCAGGGGAGAUUUCUCAACCACGACCUAAGAAGCAUCAAAGGGAAUGUGGCAAGUGUGACUCCAUUCAAAUCAAGAGCUCCCACUUACCGAAGGACACUAAGGGAACCAAAGGAAGGCCAGAGGGGCAGAAUCAACGUGCGGCACACAAAUCUUUAGUUUUCUACUAUUGCCGCAACCAGUCACCACAAAUGGAGUGGCUUGAAACAACAAGAACUCGCCACCUCCUGGCUCAGUAGAUCUGGAGUCCCUGGGCCUUACUGGGCCAGCAGGCAGGACUCAGCAGUGGUGGCUCCUUCCAGGGUUCUAGGGGAGAACCUGCUUCCUUGCCUUUUCCAGCCCCAGGGGUCACUGGCAUUCAUUGGCCCGGACUCCUUCCCCCAACCCCAAAGCCAGCAGCACCACAUCUCUCUGACCCUUCAUCCGUUGUCCCCUCUCCCCCCAAGCCCCAUGGGACAGGGUCUCCACUCCUGAGACUCAUGGGAUUAGACUAGGCCUACCUGGAUGAUCUGGGAUCCUCUCCCAUGUCCAGGUCUCUAUCCCUAACCACAUCAGCAAAGUCUCUUUUGCCAUGGAAGGUAUUUGCAGGCUCUGACUUUGUGUGUAUUAGGGCAGGACAUUUUUGGCGGGGCAGUGGUGGGGGCAGGGAAUUAUUCUGCCUACCAUGCCUUAUACAAAAAUAAAUAAAUCACAGGCUUAUACCUGAAAGAAUUCCUGCAAAUAAUAAAAGAAUUAGAGCAGCUCAGUUAAAUAAAAAAAGGUAUGAGAUGUGAACAGACACUUCACAGAAGAUGACAUGCAGGGGAGCAAGGUAUUUAUCAAAAAGUGCUCCACUUUUCACUUACCAGAGAAAUGCAAAUCAGCACCCAAAGGAGUCACUGCGGCACCCUCAUCUGAGCCUCAGAAGUUAGAAAGAUGGAUAGCACCAGUGUCAAAGGUGACUGUGGGAGGGAGAUUUGCAUACACUGCUAGUAACAAUGCGAAUUGAUGGAACCAACCUGGAAAAUGGCUUGGCAUCAACUGUUGGAGAAGAAGACACACAGUCCUCUAACCUGCCAGUCCCACAUCAGGGCCUGGAUAUGGCCGUCAUGUGUACCAGGGAGCAUGGCCAGGAAUCUUUACAGCCAAAUACUCACCAUAGCACCAAACUGGAAUCAGCCGACAUACCCAUCAGGAAGAGAAUGGAUGUUAAAAAAUGCAAGGAUAGCCAUUGGGUAGAACGCCAUACAGCCAUGACAAUUACACAGUGACACCUACACACAAGGAGCAUGAGUCUCACAAACAUGGCAGCAAAAGGAGCCUGUUCAAGAGGGUAUGUGCUAUGGAUUCCAUUGUAGAUAAAGUUUUUCAAAAGCAAAAGUAGCCAAUGGUAUUUUGGAUGCAUAUUUAGGUGGUAAAUGUAUACAGGAAAAAUAAGAAAGUGAUUGUAUUUGAGGGUGGGACCACAUGGUGACUGGGAAGGGACAGGGACAAGCCUCUGGGGUUCUGGCAAUGCUCUGUUUCUUGACCCAGGUGGUGAUUGUAAGGAUGUUUGUUAACUAGUGAUGAAAAUAAUUAAGCUGUACUUUUGCUUUAUACACUUUUGAGUACAUGUUAUGUUCCACAAUUUAAAAACUACUUAUAAAGAAACUGCACAUGCUUGGAUCCAGGAACAUGAGCUACAGGCACAUCCUCCACUGAUGCCCAGUGUUCUUGACUCAAUACCUGUAAGGAGAGGUCCUUGUAGCCCAUUGGGGGCUGACCAGACCCUACUACGCCCCUGCCACAAUCUCUAGUCCAUCACAAAAUCCACUAUUGGGAUAGUACUUUCGUCCCUCAGUAGGUAAGCAUUUUUACAACCUAGGAAGACUUAGCUUUAAGUCUAGAAAUGAUUAGUAUAAAUAUAAAAUAUAAAUAUGAUUAAUAUAAAUAUAAAAUAGCCAUAGAAAUAUGCCUUUUAGUUUGUUUUUUGAGACAGAGUUUUACUCUGCCACCCAGGCUGGAGUGCAGUGGCGUGAUCUCAGCUCACUGCAAUCUCCACCUCCCAGGUUCAAGAGAUUCUCAUGCUUCAGCCUCCCAAGUAGCUGGGAUCACAGGCACACACAACCAUGCCCAGCAAUUUUUUUGUAUUUUUAGUAGAGAUGGGGUUUCGCCGUGUUGGCCAGGCUGGUCUUGAACUCCCGACCUCAAGUGAUCCACCCGCCUCUGCCUCCCAAAUUGCUGAGAUUACAGGCGUGAGACACUGUGCCUGGCCAAAAUAUGCCUUUUGUAUUAAGGAAUCUGGACAGGUUUGAUUUUUCACAGUCUUGUAAUGUUUAAAUAAUUUGGCCUAUUAUGAAGAAUCUCACAAAUCCAAUAUAAAAUGUGGAACUAACUAAUCAAAAUCAUCUUGUAAUAUUACAUGGAAAUCUUAGUGCGUUUAUACACGGUAUUGGCAUAUUUAAGAGACUUUGAGCUCAUUGCAUUUCUAAGUUAAAUUAUUAGAUUUCUUAAGAUUUAAGUUAAAUUAUUAGAUUUUUAAAGAUUAAUUAGUGCUAAGGAGGGUUUUCUCAUUAGACAGCUGAAAUGCCGCAGGAGAAAUUUGAGUGUAUUCCACUUCUUAUUGCAAUUUUAAAUGUUUGAAGUUAUUUAAAGAACUAAAUUUAUGGUAUCCAAAAGCUCUAAAAAGGUGACUCUUAAGAUUUGCAGGUCUUAUAAAUAGAAAAACAAGAACUGUAAGCCAAACUUAAAAUAUUCAGGAUGAAUUGAGUUUUUGAAUUUGUAGCUUUCAGAAACUGAACAUUAAUUUUAAGAAGCAAAGCAGGCUGGGCACAGUGGCUCACGCCUGUAAUCCUAGCACUUUAGGAGGCUGAAGUGGGUGGAUCACUUGAGAUCAGGAGUUCAAGACCAGCCUGGCCAACAUGAUGAAACCUCCUCUCUACUAAAAAUACAAAACUCCGCCAGAAAUCGCUUGAUCCCGGGAGGUGGAGGUUGCAGUGAGCUGAGAUCGUGCCACUGCACUCCAGCCUGGGGAACAGAGCGAGAUUCCGCCUCAAAAAAAAAAUAAAAAUAAAAAGAAGAAGAAGAAGAAGGAGAAAGAGGGAGAGGGAGAGGGAGAGGGAGAGGGAGAGGGAGAGGGAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAGGAAGAGGAAGAGGAAGAGGAAGAGGAAGAGGAAGAGGAAGAAGAAGAAGAAGAGGAAGAAGAAGAAGAAGCAGCAGCAGCGGCCAGGCGCGGUGGCUCACGCUUGUAAUCCCAGCACUUUGGGAGGCCGAGGCGGGCGGAUCACAAGGUCAGGAGAUCAAGACCAUCCUGGCUAACAUGAUGAAACCCCGUCUCUACUAAAAAUACAAAAAAAUUAGCCGUUCAUGGUGGGGGAUGCCUAUCGUCCCAGCUACUCGAGAAGCUGAGGCAGGAGAAUGGCGUGAACCCAGGAGGCAGAGGUUGAAGUGAGCCGAGAUCGCACCACUGCACUCCAGCCUGGGCGACAGAGCGAGACUCUGUCUCAAAAUAAAAGAAGCAAAGCAAGCUUAUGAAGAGAUGAAGAGUCUUUUCCCAUCACCAAUUCCUCCCCAACUCACAUCAGCAGAACUGAGAGAGCUUUUGUGAUUUGAGGGAUAAAGCUGAAUGGGUGAAAAGAAAUCAAGCCCUCCUCCUCUUGGGCCAGUGCUCUUCUUCCUGGCCAUGGGACCUCUCAAGUAGGAGUGUAGGCGUGGGCCCAUCCAGCAACAUUUGGGCAUUCGUGGACAUCCACAUAGUGUUGUUUCUGUUCUUUUCCUCUCCUUCCUCAUCUUCUCUCGUCUUUGUUGAAUAUUUUUAUUAUCCCGUCACCUCCUCUAUCAGCUUAUAACUUGUUCAUUCUUUUCCUAUCUUUUGGUGUUUAUGCUUGCGAUUGCAAUAUAUAGCCUUGAUUUUUUACGGUAUACUAUAAAUUAUUCCUUCUACCACUUUACCAAUGAAGACUUUGAAACACCUCUAACUACAUUCACUCCCUUCUGCUUUUUAUGCCAUUCUUGCCGCCAUGCUAUGAUACAUUUAUUUAAAGUCCUGCAAGAAAUGGCUAUUAGUAUUGUUUUGUGCAGUCCGUAUUCAUUUUUACCACAUUUUUACACUUUAUGUUGCCCUUUAUUCCUUCUUCUAUUUUAUUAUUAUUAUUAUUUUUGGUGUGAGAUCAUCUUCUUGCUGCCUGACAAACUCCCUUUCAUAUAUAUUUUUUAUUUUUAUUUUUUGAAACAGGGUCUCACUCUGUCCCCCAGGCUGGAGUGCAGCGGUAUGACCUUAGCUCACUGCAACCUCCACCUCCUGGGCUCAAACAAUUCUCCUGCCUCAGCUUCCCGUGUAGCUGGGACUACAGGUGUGCACCACUACGCUGGGCUAAUUUUUGUAUUUUUUGGUAGAGAUGGGGUUUCGCCAUGUUAGCCAGGCUGCUCUUGAACUCCUGACCUCAAGUGAUCCACCCGCCUCAGCCUCCCAAAGUGCUAGGAUUACAGAUGUGAGACACCGUGCCCAGCCUCAUAUAUUUUUUGAUGAAAGUCUGCUGAGGAUGAAUUCUGUCCACUUUUAUUAUCUGAAAACAUCUUUAUUUUGCCUCAUUUUAAAUAGUAUUUAGAUUGGGUGUAGACUUCUAUAUUGCCAAUUAGUUUCUUUUAGCACUGUAAAUACAGAUGUCCAGUAUUUUCAGAUUCAGUUAUUUCAGCUGAAAAGCUAGCUGAAAGUCUUGUUGCUCCUCUGAAGGUAAUAUGACUUUUUUCAAAAAAUACAUUUAUAAAAUUUUUUUUCUUUGCCUUGAUAGUUUUACUACAAGGUGCCUGGAUGAGACUUUCUCUGAAUUUGUCUUGCUUGGGGUUCAUAGAAUCUGUGACUUGAUGUCUUUCAUGAGUUUUGAAAAAUGCUAGCCAUUAUCUCUUAAAUAUUGCUAUUACUCUACUCCCUCUUCUCUUUCAGAUAUUUCAGUUACACCAAUGGCCAAUGUUUGCUCGUGUCUCAUAUGUCUCUUGUUCUAGUUUCUGGAUUUGUAUUCUUUUUUCCUUUUCACAUUCAGUCUGGAUAUUUUCUGCUGACCUAUAUUCCAGUUCACUAAUAAUGCUUUUCACUGUAUCUAAUUUGCUUAUAAAUAGAAAACCAUUGAUUGAGUUAUUAAUUUCAGUUAUAGAAUAGCCAGUGUAGACUCCAAUGCUUGGCUCCACUUCUCCACUUUUUCACCUAUUUUUUUCACCAUCUUCCAUUUUCUUCAACACACCAGUCAGAGUCGUUUUUAAAGACAUUUUAAACACCUCAGUGGCCUGUAGAUCUUAUCUUCUGUUUUUUGUUUCUUUUUAAUCUUAGUUUUUUGGCACACUUGGAGGGUUUUGAUUGAAUGCUAGACAUAGUAUUCAGGAAGGCAGAGAGGAUUUUUUUUUAAGUCAGAUUUUUUGAGGUAUAAUUUAAUACAGUAAAAUUCACCUAUUUUAGUUCAGUUCUAAGAGUUUCCUCUGUGACUUUUCCUUUGGCCCAUGGUUUAUUUAAAAUUGUGUUCUUUUACUUCCAAAUUAUUUGGGAUUUUUCUAGAUAUCUUUCUGUUCUUGAUUUCUGGCUUACCUCUAUCAGGGUCAGAGAACAAACUUAAUAUGAUUUCAAUUAUUUUAAAUUUGCCAAUGUUUAUUUUAUGGCCCAGAAUAUGGUCUAUGUUGGUGAAAGUUCAAUUUGAACUUGAAAAGAAUAUGUUUUAUGCUGUUGUCUACUGAAAAGUCUAUAUAUAAAAAAUAGAUUAAUAAACUGAUUAAUAGCCUGGUUCACCA-3'- Poly-A tail
  • Coding region
;
DNA
DNA (Gene ID: 2219)
ficolin 1
strand -
FCNM
NCBI CDS gene sequence (981 bp)
5'-ATGGAGCTGAGTGGAGCCACCATGGCCCGGGGGCTCGCTGTCCTGCTAGTCTTGTTCCTGCATATCAAGAACCTGCCTGCCCAGGCTGCGGACACATGTCCAGAGGTGAAGGTGGTGGGCCTGGAGGGCTCTGACAAGCTCACCATTCTCCGAGGCTGCCCGGGGCTGCCCGGGGCCCCAGGGCCAAAGGGAGAGGCAGGTGTCATTGGAGAGAGAGGAGAACGCGGTCTCCCTGGAGCCCCTGGAAAGGCAGGACCAGTGGGGCCCAAAGGAGACCGAGGAGAGAAGGGGATGCGTGGAGAGAAAGGAGACGCTGGGCAGTCTCAGTCGTGTGCGACAGGCCCACGCAACTGCAAGGACCTGCTAGACCGGGGGTATTTCCTGAGCGGCTGGCACACCATCTACCTGCCCGACTGCCGGCCCCTGACTGTGCTCTGTGACATGGACACGGACGGAGGGGGCTGGACCGTTTTCCAGCGGAGGATGGATGGCTCTGTGGACTTCTATCGGGACTGGGCCGCATACAAGCAGGGCTTCGGCAGTCAGCTGGGGGAGTTCTGGCTGGGGAATGACAACATCCACGCCCTGACTGCCCAGGGAAGCAGCGAGCTCCGTGTAGACCTGGTGGACTTTGAGGGCAACCACCAGTTTGCTAAGTACAAATCATTCAAGGTGGCTGACGAGGCAGAGAAGTACAAGCTGGTACTGGGAGCCTTTGTCGGGGGCAGTGCGGGTAATTCTCTAACGGGCCACAACAACAACTTCTTCTCCACCAAAGACCAAGACAATGATGTGAGTTCTTCGAATTGTGCTGAGAAGTTCCAAGGAGCCTGGTGGTACGCCGACTGTCATGCTTCAAACCTCAATGGTCTCTACCTCATGGGACCCCATGAGAGCTATGCCAATGGTATCAACTGGAGTGCGGCGAAGGGGTACAAATATAGCTACAAGGTGTCAGAGATGAAGGTGCGGCCCGCCTAG-3'
NCBI CDS gene sequence with introns (location: 134909798.. 134917871) (8074 bp)Download
NCBI CDS gene sequence with introns, 5'UTR and 3'UTR (location: 134903232.. 134917912) (14681 bp)Download
NCBI gene sequence (location: [134903232.. 134917912 + 1000]) (15681 bp)Download
Cite How to cite